BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22693988)

  • 1. Payer coverage for patients enrolled onto clinical trials: making the process easy and transparent for everyone.
    Palackdharry CS; Evans DL; McDonough RS; Clarke ME; Cross JD; Klein IM; Reisman L
    Am J Manag Care; 2012 May; 18(5 Spec No. 2):SP91-7. PubMed ID: 22693988
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editors: response to payer coverage for patients enrolled onto clinical trials.
    Wong YN; Ward J; Neuss M
    Am J Manag Care; 2012 Nov; 18(11):e438. PubMed ID: 23198753
    [No Abstract]   [Full Text] [Related]  

  • 3. Partnering with a payer to develop a value-based medical home pilot: a West Coast practice's experience.
    Bosserman LD; Verrilli D; McNatt W
    Am J Manag Care; 2012 May; 18(5 Spec No. 2):SP88-90. PubMed ID: 22693987
    [No Abstract]   [Full Text] [Related]  

  • 4. Third-party payers and the cost of biomedical research.
    Iltis AS
    Kennedy Inst Ethics J; 2005 Jun; 15(2):135-60. PubMed ID: 16149205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient care cancer clinical trials at the National Cancer Institute: a resource for payers and providers.
    Pearson D
    Manag Care Q; 2002; 10(1):33-7. PubMed ID: 15988953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paying for patient care in treatment research--who is responsible?
    Wittes RE
    Cancer Treat Rep; 1987 Feb; 71(2):107-13. PubMed ID: 3100033
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effectiveness research in the neurosciences.
    Johnston SC; Hauser SL
    Ann Neurol; 2009 Feb; 65(2):A6-8. PubMed ID: 19260031
    [No Abstract]   [Full Text] [Related]  

  • 8. Researchers facing increasing costs for clinical research, with few solutions.
    Erdmann J
    J Natl Cancer Inst; 2005 Oct; 97(20):1492-4. PubMed ID: 16234558
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers to clinical trial enrollment: are state mandates the solution?
    Hillner BE
    J Natl Cancer Inst; 2004 Jul; 96(14):1048-9. PubMed ID: 15265958
    [No Abstract]   [Full Text] [Related]  

  • 10. Routine patient care in clinical trials: whose cost is it anyway?
    Berlyn D
    J Law Health; 2001-2002; 16(1):77-102. PubMed ID: 14650773
    [No Abstract]   [Full Text] [Related]  

  • 11. Researching the cost of research.
    Wright JR; Levine MN
    J Clin Oncol; 2003 Nov; 21(22):4081-2. PubMed ID: 14559890
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to economic forces buffeting the community of neurosurgery.
    Bean JR
    Clin Neurosurg; 2009; 56():70-1. PubMed ID: 20214035
    [No Abstract]   [Full Text] [Related]  

  • 13. State payer mandates to cover care in US oncology trials: do science and ethics matter?
    Taylor PL
    J Natl Cancer Inst; 2010 Mar; 102(6):376-90. PubMed ID: 20197514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of information on legislative mandates and consensus-based programs addressing payment of the costs of routine care in clinical trials through the World Wide Web.
    Monaco V
    Cancer; 2004 Dec; 101(11):2709-10; author reply 2710. PubMed ID: 15382087
    [No Abstract]   [Full Text] [Related]  

  • 15. Stat bite: State mandates for insurance coverage of clinical trials.
    J Natl Cancer Inst; 2003 Sep; 95(17):1269. PubMed ID: 12953077
    [No Abstract]   [Full Text] [Related]  

  • 16. Who pays for long-term care? Form follows funding in long-term care as new payment systems emerge and old ones evolve.
    Bonifazi WL
    Contemp Longterm Care; 1998 Oct; 21(10):76-8, 80, 82. PubMed ID: 10346501
    [No Abstract]   [Full Text] [Related]  

  • 17. Private-payer profits can induce negative Medicare margins.
    Stensland J; Gaumer ZR; Miller ME
    Health Aff (Millwood); 2010 May; 29(5):1045-51. PubMed ID: 20299385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing coverage for clinical trials.
    Newcomer LN
    Eff Clin Pract; 1999; 2(5):244-6. PubMed ID: 10623058
    [No Abstract]   [Full Text] [Related]  

  • 19. More states mandate coverage of clinical trial costs, but does it make a difference?
    McBride G
    J Natl Cancer Inst; 2003 Sep; 95(17):1268-9. PubMed ID: 12953076
    [No Abstract]   [Full Text] [Related]  

  • 20. Third party reimbursement for participation in cancer clinical trials: a proposal for legislation.
    Plaue GM
    J Contemp Health Law Policy; 2000; 16(2):305-54. PubMed ID: 10921232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.